Corporate
When Brent Gledhill was elected as William Blair’s chief executive officer, replacing his predecessor John Ettelson, he took the reigns of the firm at an incredibly exciting time, and represented the final piece of a strategic transition in leadership. Gledhill joined Blair in 1997 as an investment banker and, in 2001, became head of the firm’s European and Asian banking group. In 2009, he was named global head of investment banking and became president of William Blair in July.
Stay up-to-date with the latest William Blair news and insights
William Blair biotech analysts Matt Phipps and Andy Hsieh discuss Andy’s innovative scoring system for evaluating investigational agents in obesity treatment. This system, highlighted in Andy’s report “Shaping the Future: Innovations and Trends in Obesity Treatment,” considers both weight loss and gastrointestinal side effects to provide a more comprehensive clinical assessment. Tune in to hear their insights on the future of obesity therapies, upcoming industry catalysts, and more.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
